Scientists reprogram Patients' own cells to hunt down blood cancer
NCT ID NCT03938987
Summary
This study is testing a personalized treatment called CAR T-cell therapy for people with aggressive lymphoma or acute lymphoblastic leukemia that has returned or not responded to standard treatments. Doctors collect a patient's own immune cells, genetically modify them in a lab to better recognize and attack cancer cells, and then infuse them back into the patient. The trial aims to find the safest and most effective dose and see how well this approach controls these difficult-to-treat cancers.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSED NON-HODGKIN LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Alberta Children's Hospital
NOT_YET_RECRUITINGCalgary, Alberta, T3B6A8, Canada
Contact
-
Cross Cancer Institute
RECRUITINGEdmonton, Alberta, T6G1Z2, Canada
Contact
-
Foothills Medical Centre
NOT_YET_RECRUITINGCalgary, Alberta, T2N2T9, Canada
Contact
-
Stollery Children's Hospital
NOT_YET_RECRUITINGEdmonton, Alberta, T6G2B7, Canada
Contact
-
Tom Baker Cancer Centre
NOT_YET_RECRUITINGCalgary, Alberta, T2N4N2, Canada
Contact
-
University of Alberta Hospital
RECRUITINGEdmonton, Alberta, T6G2B7, Canada
Contact
Conditions
Explore the condition pages connected to this study.